Should you buy Synopsys stock now?
No, the technical signal for Synopsys is currently SELL. Synopsys trades at $408.86 as of 8/6/2026. The overall technical signal is: Strong Sell. The technical analysis shows the following: MACD is negative (bearish trend) at -14.067 with rising momentum (signal: -18.130); RSI is at 46.4 (neutral zone); the stock is in a short-term uptrend (price above the 20-day average); the analyst price target of $564.43 points to 38.0% upside. The stock is in a broader downtrend (below SMA50/SMA200). Buying in a downtrend is generally not recommended. This is a technical observation based on current data, not investment advice.
What is the price target for Synopsys stock?
The average analyst price target for Synopsys is $564.43. The current price is $408.86, which gives an upside of 38.0%. Based on this, the stock is considered undervalued. The fair value range (±10% of the price target) is between $507.99 and $620.87.
Is Synopsys a dividend stock?
No, Synopsys does not currently pay a dividend to shareholders. The company reinvests its profits in growth instead of paying dividends.
What is the risk of Synopsys stock?
Synopsys is rated as a stock with high risk. the annual standard deviation is 56.8%, which classifies the stock as high risk.
Is Synopsys overvalued?
No, Synopsys is considered undervalued based on the analyst price target (38.0% upside). Synopsys has the following valuation ratios: a P/E ratio of 92.8 (highly valued), a P/S ratio of 8.9, a P/B ratio of 2.4. The analyst price target suggests that the stock is undervalued by 38.0%.
Is Synopsys overbought?
No, Synopsys is not overbought. RSI is at 46.4 (neutral zone). The technical indicators show: RSI is at 46.4 (neutral zone between 30-70), which signals neither overbought nor oversold. In addition, the price is 2.6% above the 20-day average (short-term uptrend). In addition, MACD is negative, but momentum is rising (possible trend reversal).
When is the next Synopsys earnings report?
Synopsys reports its next earnings on August 26, 2026. The stock currently trades at $408.86. With a P/E ratio of 92.8, the market will be watching closely whether earnings meet expectations.
Is Synopsys shorted?
Yes, Synopsys is shorted with 2.9% of the free float sold short. This is a moderate level of short selling, within the normal range for most stocks. Data is updated daily based on official filings with the SEC.
Are insiders buying Synopsys stock?
No, insiders are not buying Synopsys shares – they are net sellers. Over the last 3 months, insiders have made 0 purchases and 9 sales. On a net basis, 12,060,984 $ worth of shares were sold. Across the last 20 reported transactions, the split is 4 purchases and 16 sales, with a net 15,618,013 $ sold. Active sellers include LEE JANET, Kankanwadi Sudhindra, Glaser Shelagh and others. Insider selling can have several explanations (e.g. planned 10b5-1 sales, portfolio diversification or taxes), but sustained selling by several insiders is worth watching closely.
Is Synopsys a good stock?
Based on our total score, Synopsys is rated as a poor stock with a total score of 29 out of 100. The stock scores below average on value, quality and momentum – it sits at the lower end of the market. The score is made up of Value: 25/100, Quality: 37/100, Momentum: 24/100. In addition: analysts see 38.0% upside to the price target; technical signal: Strong Sell. Whether Synopsys is a good investment depends on your time horizon, risk profile and portfolio. This is a data-driven observation, not investment advice.
What is the outlook for Synopsys stock?
The outlook for Synopsys based on current data: the average analyst price target is $564.43 (+38.0%); the stock is in a downtrend (below SMA50 and SMA200); the next earnings report is due on 8/26/2026, which can move the price; the P/E ratio is 92.8 (high – the market expects growth). Keep in mind that stock prices are affected by many factors, including earnings reports, the economy and market sentiment. Past returns are no guarantee of future returns.
Why is Synopsys stock rising?
Synopsys is rising right now. The technical indicators show: the price is 2.6% above the 20-day average; insiders have mostly been selling the stock recently. For the latest context, see our technical analysis, insider section and news overview above.
How high can Synopsys go?
The average analyst price target for Synopsys is $564.43, which corresponds to a potential gain of 38.0% from the current price of $408.86. Keep in mind that price targets are estimates, not guarantees. Actual price moves depend on earnings, market conditions and unexpected events.
How low can Synopsys fall?
We lack enough history to give a specific floor for Synopsys. Remember: past price swings are no guarantee for the future — a stock can fall further than the last 52 weeks suggest, especially on profit warnings, sector crises or a market crash. Use stop-loss orders and spread your portfolio to limit losses in single stocks.
What does Synopsys do?
Synopsys, Inc. provides design IP solutions in the semiconductor and electronics industries. It operates in two segments, Design Automation and Design IP. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verificati... The company belongs to the Teknologi sector, more specifically the Software - Infrastructure industry, is headquartered in USA, and is traded on the USA Stocks. See the key figures, earnings history and price development above to evaluate Synopsys as an investment.
Did Synopsys raise or lower its guidance?
Over the last 60 days we have not registered a guidance raise or cut from Synopsys. The company can still adjust its guidance at quarterly reports or between reports — see the earnings history and the news overview above.
Is Synopsys making money or losing money?
Yes, Synopsys is making money, not losing it. The company has a profit margin (the share of revenue left over as profit) of 8.9% — which is moderate. The operating margin (profit before interest and taxes) is 10.4%. At a P/E ratio of 92.8, you currently pay 92.8 dollars for every dollar of the company's annual earnings. A consistently profitable company is usually more resilient than growth stocks that are not yet making money.
Can Synopsys go bankrupt?
The bankruptcy risk of Synopsys is rated as low. Altman Z2 (a model for assessing financial distress) is 3.11 — that places the company in the healthy zone. The company has a healthy balance sheet with limited debt relative to earnings and assets. The Piotroski score (financial health 0-9, higher is better) is 5 — which is average. Debt relative to equity is 45% (low). Remember: models like Altman Z2 are statistical — unexpected shocks (fraud, a sector collapse, lawsuits) can always happen. Spread your portfolio.
Does Synopsys have a lot of debt?
No, Synopsys has low debt relative to equity. The debt-to-equity ratio (D/E — interest-bearing debt to equity) is 45%. For the teknologi sector, anything below 80% counts as low debt. Note: D/E levels are highly sector-specific — a bank at 300% debt is normal, a tech stock at 300% is extremely leveraged. Always compare with similar companies in the same sector. Can Synopsys service its debt? Could struggle to service its debt — the interest coverage ratio (how many times earnings can cover interest payments) is 1.1x, and net debt equals 5.0 years of earnings (EBITDA).
